nodes	percent_of_prediction	percent_of_DWPC	metapath
Cephalexin—ALB—Prednisone—ankylosing spondylitis	0.167	0.188	CbGbCtD
Cephalexin—SLC22A8—Methotrexate—ankylosing spondylitis	0.142	0.159	CbGbCtD
Cephalexin—SLC22A6—Methotrexate—ankylosing spondylitis	0.0986	0.11	CbGbCtD
Cephalexin—CYP3A4—Methylprednisolone—ankylosing spondylitis	0.0866	0.097	CbGbCtD
Cephalexin—ALB—Methotrexate—ankylosing spondylitis	0.084	0.0941	CbGbCtD
Cephalexin—CYP3A4—Triamcinolone—ankylosing spondylitis	0.0656	0.0735	CbGbCtD
Cephalexin—CYP3A4—Betamethasone—ankylosing spondylitis	0.0563	0.0631	CbGbCtD
Cephalexin—CYP3A4—Prednisolone—ankylosing spondylitis	0.0555	0.0622	CbGbCtD
Cephalexin—CYP3A4—Prednisone—ankylosing spondylitis	0.0524	0.0588	CbGbCtD
Cephalexin—CYP2D6—Dexamethasone—ankylosing spondylitis	0.0515	0.0577	CbGbCtD
Cephalexin—CYP3A4—Dexamethasone—ankylosing spondylitis	0.0327	0.0367	CbGbCtD
Cephalexin—Arthropathy—Prednisolone—ankylosing spondylitis	0.00174	0.0162	CcSEcCtD
Cephalexin—Arthropathy—Triamcinolone—ankylosing spondylitis	0.0016	0.0149	CcSEcCtD
Cephalexin—Arthropathy—Methylprednisolone—ankylosing spondylitis	0.0016	0.0148	CcSEcCtD
Cephalexin—Vaginal discharge—Methotrexate—ankylosing spondylitis	0.00158	0.0147	CcSEcCtD
Cephalexin—Arthropathy—Dexamethasone—ankylosing spondylitis	0.00146	0.0135	CcSEcCtD
Cephalexin—Arthropathy—Betamethasone—ankylosing spondylitis	0.00146	0.0135	CcSEcCtD
Cephalexin—Arthropathy—Prednisone—ankylosing spondylitis	0.00127	0.0118	CcSEcCtD
Cephalexin—Blood alkaline phosphatase increased—Methylprednisolone—ankylosing spondylitis	0.00122	0.0113	CcSEcCtD
Cephalexin—Osteoarthritis—Prednisolone—ankylosing spondylitis	0.00115	0.0107	CcSEcCtD
Cephalexin—Osteoarthritis—Triamcinolone—ankylosing spondylitis	0.00106	0.00982	CcSEcCtD
Cephalexin—Osteoarthritis—Methylprednisolone—ankylosing spondylitis	0.00106	0.0098	CcSEcCtD
Cephalexin—Vaginal inflammation—Methotrexate—ankylosing spondylitis	0.000964	0.00894	CcSEcCtD
Cephalexin—Osteoarthritis—Dexamethasone—ankylosing spondylitis	0.000961	0.00891	CcSEcCtD
Cephalexin—Osteoarthritis—Betamethasone—ankylosing spondylitis	0.000961	0.00891	CcSEcCtD
Cephalexin—Breast disorder—Methylprednisolone—ankylosing spondylitis	0.000955	0.00886	CcSEcCtD
Cephalexin—Alanine aminotransferase increased—Methylprednisolone—ankylosing spondylitis	0.000932	0.00864	CcSEcCtD
Cephalexin—Vaginal infection—Methotrexate—ankylosing spondylitis	0.00091	0.00844	CcSEcCtD
Cephalexin—Aplastic anaemia—Methotrexate—ankylosing spondylitis	0.000905	0.00839	CcSEcCtD
Cephalexin—Osteoarthritis—Prednisone—ankylosing spondylitis	0.000837	0.00776	CcSEcCtD
Cephalexin—Infestation NOS—Methylprednisolone—ankylosing spondylitis	0.000814	0.00755	CcSEcCtD
Cephalexin—Infestation—Methylprednisolone—ankylosing spondylitis	0.000814	0.00755	CcSEcCtD
Cephalexin—Haemoglobin—Prednisolone—ankylosing spondylitis	0.000801	0.00743	CcSEcCtD
Cephalexin—Haemorrhage—Prednisolone—ankylosing spondylitis	0.000797	0.00739	CcSEcCtD
Cephalexin—Alanine aminotransferase increased—Prednisone—ankylosing spondylitis	0.000738	0.00685	CcSEcCtD
Cephalexin—Haemoglobin—Triamcinolone—ankylosing spondylitis	0.000736	0.00683	CcSEcCtD
Cephalexin—Haemoglobin—Methylprednisolone—ankylosing spondylitis	0.000735	0.00681	CcSEcCtD
Cephalexin—Haemorrhage—Triamcinolone—ankylosing spondylitis	0.000733	0.0068	CcSEcCtD
Cephalexin—Haemorrhage—Methylprednisolone—ankylosing spondylitis	0.000731	0.00678	CcSEcCtD
Cephalexin—Hallucination—Methylprednisolone—ankylosing spondylitis	0.000727	0.00675	CcSEcCtD
Cephalexin—Connective tissue disorder—Methylprednisolone—ankylosing spondylitis	0.000718	0.00666	CcSEcCtD
Cephalexin—Osteoarthritis—Methotrexate—ankylosing spondylitis	0.000699	0.00649	CcSEcCtD
Cephalexin—Neutropenia—Prednisone—ankylosing spondylitis	0.000676	0.00627	CcSEcCtD
Cephalexin—Haemoglobin—Dexamethasone—ankylosing spondylitis	0.000668	0.0062	CcSEcCtD
Cephalexin—Haemoglobin—Betamethasone—ankylosing spondylitis	0.000668	0.0062	CcSEcCtD
Cephalexin—Haemorrhage—Dexamethasone—ankylosing spondylitis	0.000665	0.00617	CcSEcCtD
Cephalexin—Haemorrhage—Betamethasone—ankylosing spondylitis	0.000665	0.00617	CcSEcCtD
Cephalexin—Hallucination—Dexamethasone—ankylosing spondylitis	0.000662	0.00613	CcSEcCtD
Cephalexin—Hallucination—Betamethasone—ankylosing spondylitis	0.000662	0.00613	CcSEcCtD
Cephalexin—Immune system disorder—Methylprednisolone—ankylosing spondylitis	0.00066	0.00612	CcSEcCtD
Cephalexin—Mental disorder—Methylprednisolone—ankylosing spondylitis	0.000641	0.00594	CcSEcCtD
Cephalexin—Angioedema—Prednisolone—ankylosing spondylitis	0.000634	0.00588	CcSEcCtD
Cephalexin—Breast disorder—Methotrexate—ankylosing spondylitis	0.000632	0.00586	CcSEcCtD
Cephalexin—Toxic epidermal necrolysis—Methotrexate—ankylosing spondylitis	0.00063	0.00584	CcSEcCtD
Cephalexin—Convulsion—Prednisolone—ankylosing spondylitis	0.000601	0.00557	CcSEcCtD
Cephalexin—Eosinophilia—Methotrexate—ankylosing spondylitis	0.000599	0.00555	CcSEcCtD
Cephalexin—Angioedema—Triamcinolone—ankylosing spondylitis	0.000583	0.00541	CcSEcCtD
Cephalexin—Haemoglobin—Prednisone—ankylosing spondylitis	0.000582	0.0054	CcSEcCtD
Cephalexin—Angioedema—Methylprednisolone—ankylosing spondylitis	0.000582	0.00539	CcSEcCtD
Cephalexin—Haemorrhage—Prednisone—ankylosing spondylitis	0.000579	0.00537	CcSEcCtD
Cephalexin—Hallucination—Prednisone—ankylosing spondylitis	0.000576	0.00534	CcSEcCtD
Cephalexin—Pancytopenia—Methotrexate—ankylosing spondylitis	0.000574	0.00532	CcSEcCtD
Cephalexin—Connective tissue disorder—Prednisone—ankylosing spondylitis	0.000569	0.00528	CcSEcCtD
Cephalexin—Anaphylactic shock—Prednisolone—ankylosing spondylitis	0.000566	0.00525	CcSEcCtD
Cephalexin—Neutropenia—Methotrexate—ankylosing spondylitis	0.000565	0.00524	CcSEcCtD
Cephalexin—Convulsion—Triamcinolone—ankylosing spondylitis	0.000553	0.00513	CcSEcCtD
Cephalexin—Convulsion—Methylprednisolone—ankylosing spondylitis	0.000551	0.00511	CcSEcCtD
Cephalexin—Arthralgia—Methylprednisolone—ankylosing spondylitis	0.000542	0.00502	CcSEcCtD
Cephalexin—Infestation—Methotrexate—ankylosing spondylitis	0.000539	0.005	CcSEcCtD
Cephalexin—Infestation NOS—Methotrexate—ankylosing spondylitis	0.000539	0.005	CcSEcCtD
Cephalexin—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—ankylosing spondylitis	0.000538	0.00499	CcSEcCtD
Cephalexin—Stevens-Johnson syndrome—Methotrexate—ankylosing spondylitis	0.000534	0.00496	CcSEcCtD
Cephalexin—Angioedema—Dexamethasone—ankylosing spondylitis	0.000529	0.0049	CcSEcCtD
Cephalexin—Angioedema—Betamethasone—ankylosing spondylitis	0.000529	0.0049	CcSEcCtD
Cephalexin—Confusional state—Methylprednisolone—ankylosing spondylitis	0.000524	0.00486	CcSEcCtD
Cephalexin—Immune system disorder—Prednisone—ankylosing spondylitis	0.000523	0.00485	CcSEcCtD
Cephalexin—Anaphylactic shock—Triamcinolone—ankylosing spondylitis	0.000521	0.00483	CcSEcCtD
Cephalexin—Anaphylactic shock—Methylprednisolone—ankylosing spondylitis	0.000519	0.00482	CcSEcCtD
Cephalexin—Hepatobiliary disease—Methotrexate—ankylosing spondylitis	0.00051	0.00473	CcSEcCtD
Cephalexin—Nervous system disorder—Methylprednisolone—ankylosing spondylitis	0.000509	0.00472	CcSEcCtD
Cephalexin—Mental disorder—Prednisone—ankylosing spondylitis	0.000507	0.0047	CcSEcCtD
Cephalexin—Skin disorder—Methylprednisolone—ankylosing spondylitis	0.000505	0.00468	CcSEcCtD
Cephalexin—Agranulocytosis—Methotrexate—ankylosing spondylitis	0.000503	0.00466	CcSEcCtD
Cephalexin—Convulsion—Dexamethasone—ankylosing spondylitis	0.000501	0.00465	CcSEcCtD
Cephalexin—Convulsion—Betamethasone—ankylosing spondylitis	0.000501	0.00465	CcSEcCtD
Cephalexin—Haemoglobin—Methotrexate—ankylosing spondylitis	0.000486	0.00451	CcSEcCtD
Cephalexin—Haemorrhage—Methotrexate—ankylosing spondylitis	0.000484	0.00449	CcSEcCtD
Cephalexin—Hepatitis—Methotrexate—ankylosing spondylitis	0.000484	0.00449	CcSEcCtD
Cephalexin—Urinary tract disorder—Methotrexate—ankylosing spondylitis	0.000478	0.00443	CcSEcCtD
Cephalexin—Urethral disorder—Methotrexate—ankylosing spondylitis	0.000474	0.0044	CcSEcCtD
Cephalexin—Musculoskeletal discomfort—Triamcinolone—ankylosing spondylitis	0.000474	0.0044	CcSEcCtD
Cephalexin—Musculoskeletal discomfort—Methylprednisolone—ankylosing spondylitis	0.000473	0.00439	CcSEcCtD
Cephalexin—Anaphylactic shock—Dexamethasone—ankylosing spondylitis	0.000472	0.00438	CcSEcCtD
Cephalexin—Anaphylactic shock—Betamethasone—ankylosing spondylitis	0.000472	0.00438	CcSEcCtD
Cephalexin—Feeling abnormal—Prednisolone—ankylosing spondylitis	0.000466	0.00433	CcSEcCtD
Cephalexin—Nervous system disorder—Betamethasone—ankylosing spondylitis	0.000463	0.0043	CcSEcCtD
Cephalexin—Nervous system disorder—Dexamethasone—ankylosing spondylitis	0.000463	0.0043	CcSEcCtD
Cephalexin—Agitation—Prednisone—ankylosing spondylitis	0.000463	0.0043	CcSEcCtD
Cephalexin—Thrombocytopenia—Dexamethasone—ankylosing spondylitis	0.000462	0.00429	CcSEcCtD
Cephalexin—Thrombocytopenia—Betamethasone—ankylosing spondylitis	0.000462	0.00429	CcSEcCtD
Cephalexin—Angioedema—Prednisone—ankylosing spondylitis	0.000461	0.00427	CcSEcCtD
Cephalexin—Dyspepsia—Triamcinolone—ankylosing spondylitis	0.000458	0.00425	CcSEcCtD
Cephalexin—Erythema multiforme—Methotrexate—ankylosing spondylitis	0.000458	0.00424	CcSEcCtD
Cephalexin—Dyspepsia—Methylprednisolone—ankylosing spondylitis	0.000457	0.00424	CcSEcCtD
Cephalexin—Urticaria—Prednisolone—ankylosing spondylitis	0.00045	0.00417	CcSEcCtD
Cephalexin—Fatigue—Triamcinolone—ankylosing spondylitis	0.000449	0.00416	CcSEcCtD
Cephalexin—Fatigue—Methylprednisolone—ankylosing spondylitis	0.000448	0.00415	CcSEcCtD
Cephalexin—Immune system disorder—Methotrexate—ankylosing spondylitis	0.000437	0.00405	CcSEcCtD
Cephalexin—Convulsion—Prednisone—ankylosing spondylitis	0.000437	0.00405	CcSEcCtD
Cephalexin—Musculoskeletal discomfort—Dexamethasone—ankylosing spondylitis	0.00043	0.00399	CcSEcCtD
Cephalexin—Musculoskeletal discomfort—Betamethasone—ankylosing spondylitis	0.00043	0.00399	CcSEcCtD
Cephalexin—Arthralgia—Prednisone—ankylosing spondylitis	0.000429	0.00398	CcSEcCtD
Cephalexin—Feeling abnormal—Triamcinolone—ankylosing spondylitis	0.000429	0.00398	CcSEcCtD
Cephalexin—Feeling abnormal—Methylprednisolone—ankylosing spondylitis	0.000428	0.00397	CcSEcCtD
Cephalexin—Unspecified disorder of skin and subcutaneous tissue—Prednisone—ankylosing spondylitis	0.000426	0.00395	CcSEcCtD
Cephalexin—Gastrointestinal pain—Methylprednisolone—ankylosing spondylitis	0.000425	0.00394	CcSEcCtD
Cephalexin—Mental disorder—Methotrexate—ankylosing spondylitis	0.000424	0.00393	CcSEcCtD
Cephalexin—Hypersensitivity—Prednisolone—ankylosing spondylitis	0.000417	0.00387	CcSEcCtD
Cephalexin—Dyspepsia—Betamethasone—ankylosing spondylitis	0.000416	0.00386	CcSEcCtD
Cephalexin—Dyspepsia—Dexamethasone—ankylosing spondylitis	0.000416	0.00386	CcSEcCtD
Cephalexin—Urticaria—Triamcinolone—ankylosing spondylitis	0.000414	0.00384	CcSEcCtD
Cephalexin—Urticaria—Methylprednisolone—ankylosing spondylitis	0.000413	0.00383	CcSEcCtD
Cephalexin—Body temperature increased—Triamcinolone—ankylosing spondylitis	0.000412	0.00382	CcSEcCtD
Cephalexin—Anaphylactic shock—Prednisone—ankylosing spondylitis	0.000411	0.00381	CcSEcCtD
Cephalexin—Abdominal pain—Methylprednisolone—ankylosing spondylitis	0.000411	0.00381	CcSEcCtD
Cephalexin—Gastrointestinal disorder—Dexamethasone—ankylosing spondylitis	0.000408	0.00378	CcSEcCtD
Cephalexin—Gastrointestinal disorder—Betamethasone—ankylosing spondylitis	0.000408	0.00378	CcSEcCtD
Cephalexin—Fatigue—Betamethasone—ankylosing spondylitis	0.000407	0.00378	CcSEcCtD
Cephalexin—Fatigue—Dexamethasone—ankylosing spondylitis	0.000407	0.00378	CcSEcCtD
Cephalexin—Nervous system disorder—Prednisone—ankylosing spondylitis	0.000403	0.00374	CcSEcCtD
Cephalexin—Skin disorder—Prednisone—ankylosing spondylitis	0.0004	0.00371	CcSEcCtD
Cephalexin—Feeling abnormal—Dexamethasone—ankylosing spondylitis	0.000389	0.00361	CcSEcCtD
Cephalexin—Feeling abnormal—Betamethasone—ankylosing spondylitis	0.000389	0.00361	CcSEcCtD
Cephalexin—Gastrointestinal pain—Betamethasone—ankylosing spondylitis	0.000386	0.00358	CcSEcCtD
Cephalexin—Gastrointestinal pain—Dexamethasone—ankylosing spondylitis	0.000386	0.00358	CcSEcCtD
Cephalexin—Hypersensitivity—Triamcinolone—ankylosing spondylitis	0.000384	0.00356	CcSEcCtD
Cephalexin—Hypersensitivity—Methylprednisolone—ankylosing spondylitis	0.000383	0.00355	CcSEcCtD
Cephalexin—Leukopenia—Methotrexate—ankylosing spondylitis	0.000377	0.0035	CcSEcCtD
Cephalexin—Urticaria—Betamethasone—ankylosing spondylitis	0.000375	0.00348	CcSEcCtD
Cephalexin—Urticaria—Dexamethasone—ankylosing spondylitis	0.000375	0.00348	CcSEcCtD
Cephalexin—Musculoskeletal discomfort—Prednisone—ankylosing spondylitis	0.000375	0.00348	CcSEcCtD
Cephalexin—Dizziness—Prednisolone—ankylosing spondylitis	0.000374	0.00347	CcSEcCtD
Cephalexin—Asthenia—Triamcinolone—ankylosing spondylitis	0.000374	0.00346	CcSEcCtD
Cephalexin—Abdominal pain—Dexamethasone—ankylosing spondylitis	0.000373	0.00346	CcSEcCtD
Cephalexin—Abdominal pain—Betamethasone—ankylosing spondylitis	0.000373	0.00346	CcSEcCtD
Cephalexin—Body temperature increased—Dexamethasone—ankylosing spondylitis	0.000373	0.00346	CcSEcCtD
Cephalexin—Body temperature increased—Betamethasone—ankylosing spondylitis	0.000373	0.00346	CcSEcCtD
Cephalexin—Asthenia—Methylprednisolone—ankylosing spondylitis	0.000373	0.00346	CcSEcCtD
Cephalexin—Pruritus—Triamcinolone—ankylosing spondylitis	0.000368	0.00342	CcSEcCtD
Cephalexin—Pruritus—Methylprednisolone—ankylosing spondylitis	0.000367	0.00341	CcSEcCtD
Cephalexin—Convulsion—Methotrexate—ankylosing spondylitis	0.000365	0.00338	CcSEcCtD
Cephalexin—Dyspepsia—Prednisone—ankylosing spondylitis	0.000362	0.00336	CcSEcCtD
Cephalexin—Arthralgia—Methotrexate—ankylosing spondylitis	0.000359	0.00333	CcSEcCtD
Cephalexin—Rash—Prednisolone—ankylosing spondylitis	0.000357	0.00331	CcSEcCtD
Cephalexin—Dermatitis—Prednisolone—ankylosing spondylitis	0.000357	0.00331	CcSEcCtD
Cephalexin—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—ankylosing spondylitis	0.000356	0.0033	CcSEcCtD
Cephalexin—Diarrhoea—Methylprednisolone—ankylosing spondylitis	0.000355	0.0033	CcSEcCtD
Cephalexin—Fatigue—Prednisone—ankylosing spondylitis	0.000355	0.00329	CcSEcCtD
Cephalexin—Headache—Prednisolone—ankylosing spondylitis	0.000355	0.00329	CcSEcCtD
Cephalexin—Confusional state—Methotrexate—ankylosing spondylitis	0.000347	0.00321	CcSEcCtD
Cephalexin—Dizziness—Triamcinolone—ankylosing spondylitis	0.000344	0.00319	CcSEcCtD
Cephalexin—Anaphylactic shock—Methotrexate—ankylosing spondylitis	0.000344	0.00319	CcSEcCtD
Cephalexin—Dizziness—Methylprednisolone—ankylosing spondylitis	0.000343	0.00319	CcSEcCtD
Cephalexin—Feeling abnormal—Prednisone—ankylosing spondylitis	0.000339	0.00314	CcSEcCtD
Cephalexin—Asthenia—Dexamethasone—ankylosing spondylitis	0.000339	0.00314	CcSEcCtD
Cephalexin—Asthenia—Betamethasone—ankylosing spondylitis	0.000339	0.00314	CcSEcCtD
Cephalexin—Nervous system disorder—Methotrexate—ankylosing spondylitis	0.000337	0.00313	CcSEcCtD
Cephalexin—Thrombocytopenia—Methotrexate—ankylosing spondylitis	0.000337	0.00312	CcSEcCtD
Cephalexin—Gastrointestinal pain—Prednisone—ankylosing spondylitis	0.000336	0.00312	CcSEcCtD
Cephalexin—Nausea—Prednisolone—ankylosing spondylitis	0.000336	0.00312	CcSEcCtD
Cephalexin—Pruritus—Dexamethasone—ankylosing spondylitis	0.000334	0.0031	CcSEcCtD
Cephalexin—Pruritus—Betamethasone—ankylosing spondylitis	0.000334	0.0031	CcSEcCtD
Cephalexin—Skin disorder—Methotrexate—ankylosing spondylitis	0.000334	0.0031	CcSEcCtD
Cephalexin—Vomiting—Triamcinolone—ankylosing spondylitis	0.000331	0.00307	CcSEcCtD
Cephalexin—Vomiting—Methylprednisolone—ankylosing spondylitis	0.00033	0.00306	CcSEcCtD
Cephalexin—Rash—Triamcinolone—ankylosing spondylitis	0.000328	0.00304	CcSEcCtD
Cephalexin—Dermatitis—Triamcinolone—ankylosing spondylitis	0.000328	0.00304	CcSEcCtD
Cephalexin—Rash—Methylprednisolone—ankylosing spondylitis	0.000328	0.00304	CcSEcCtD
Cephalexin—Dermatitis—Methylprednisolone—ankylosing spondylitis	0.000327	0.00303	CcSEcCtD
Cephalexin—Urticaria—Prednisone—ankylosing spondylitis	0.000327	0.00303	CcSEcCtD
Cephalexin—Headache—Triamcinolone—ankylosing spondylitis	0.000326	0.00302	CcSEcCtD
Cephalexin—Headache—Methylprednisolone—ankylosing spondylitis	0.000325	0.00302	CcSEcCtD
Cephalexin—Abdominal pain—Prednisone—ankylosing spondylitis	0.000325	0.00302	CcSEcCtD
Cephalexin—Body temperature increased—Prednisone—ankylosing spondylitis	0.000325	0.00302	CcSEcCtD
Cephalexin—Diarrhoea—Betamethasone—ankylosing spondylitis	0.000323	0.003	CcSEcCtD
Cephalexin—Diarrhoea—Dexamethasone—ankylosing spondylitis	0.000323	0.003	CcSEcCtD
Cephalexin—Musculoskeletal discomfort—Methotrexate—ankylosing spondylitis	0.000313	0.0029	CcSEcCtD
Cephalexin—Dizziness—Dexamethasone—ankylosing spondylitis	0.000312	0.0029	CcSEcCtD
Cephalexin—Dizziness—Betamethasone—ankylosing spondylitis	0.000312	0.0029	CcSEcCtD
Cephalexin—Nausea—Triamcinolone—ankylosing spondylitis	0.000309	0.00287	CcSEcCtD
Cephalexin—Nausea—Methylprednisolone—ankylosing spondylitis	0.000309	0.00286	CcSEcCtD
Cephalexin—Hypersensitivity—Prednisone—ankylosing spondylitis	0.000303	0.00281	CcSEcCtD
Cephalexin—Dyspepsia—Methotrexate—ankylosing spondylitis	0.000303	0.00281	CcSEcCtD
Cephalexin—Vomiting—Dexamethasone—ankylosing spondylitis	0.0003	0.00279	CcSEcCtD
Cephalexin—Vomiting—Betamethasone—ankylosing spondylitis	0.0003	0.00279	CcSEcCtD
Cephalexin—Rash—Dexamethasone—ankylosing spondylitis	0.000298	0.00276	CcSEcCtD
Cephalexin—Rash—Betamethasone—ankylosing spondylitis	0.000298	0.00276	CcSEcCtD
Cephalexin—Dermatitis—Dexamethasone—ankylosing spondylitis	0.000298	0.00276	CcSEcCtD
Cephalexin—Dermatitis—Betamethasone—ankylosing spondylitis	0.000298	0.00276	CcSEcCtD
Cephalexin—Gastrointestinal disorder—Methotrexate—ankylosing spondylitis	0.000297	0.00275	CcSEcCtD
Cephalexin—Fatigue—Methotrexate—ankylosing spondylitis	0.000296	0.00275	CcSEcCtD
Cephalexin—Headache—Dexamethasone—ankylosing spondylitis	0.000296	0.00274	CcSEcCtD
Cephalexin—Headache—Betamethasone—ankylosing spondylitis	0.000296	0.00274	CcSEcCtD
Cephalexin—Asthenia—Prednisone—ankylosing spondylitis	0.000295	0.00274	CcSEcCtD
Cephalexin—Pruritus—Prednisone—ankylosing spondylitis	0.000291	0.0027	CcSEcCtD
Cephalexin—Feeling abnormal—Methotrexate—ankylosing spondylitis	0.000283	0.00263	CcSEcCtD
Cephalexin—Diarrhoea—Prednisone—ankylosing spondylitis	0.000281	0.00261	CcSEcCtD
Cephalexin—Gastrointestinal pain—Methotrexate—ankylosing spondylitis	0.000281	0.00261	CcSEcCtD
Cephalexin—Nausea—Dexamethasone—ankylosing spondylitis	0.000281	0.0026	CcSEcCtD
Cephalexin—Nausea—Betamethasone—ankylosing spondylitis	0.000281	0.0026	CcSEcCtD
Cephalexin—Urticaria—Methotrexate—ankylosing spondylitis	0.000273	0.00253	CcSEcCtD
Cephalexin—Dizziness—Prednisone—ankylosing spondylitis	0.000272	0.00252	CcSEcCtD
Cephalexin—Body temperature increased—Methotrexate—ankylosing spondylitis	0.000272	0.00252	CcSEcCtD
Cephalexin—Abdominal pain—Methotrexate—ankylosing spondylitis	0.000272	0.00252	CcSEcCtD
Cephalexin—Vomiting—Prednisone—ankylosing spondylitis	0.000262	0.00243	CcSEcCtD
Cephalexin—Rash—Prednisone—ankylosing spondylitis	0.000259	0.00241	CcSEcCtD
Cephalexin—Dermatitis—Prednisone—ankylosing spondylitis	0.000259	0.0024	CcSEcCtD
Cephalexin—Headache—Prednisone—ankylosing spondylitis	0.000258	0.00239	CcSEcCtD
Cephalexin—Hypersensitivity—Methotrexate—ankylosing spondylitis	0.000253	0.00235	CcSEcCtD
Cephalexin—Asthenia—Methotrexate—ankylosing spondylitis	0.000247	0.00229	CcSEcCtD
Cephalexin—Nausea—Prednisone—ankylosing spondylitis	0.000244	0.00227	CcSEcCtD
Cephalexin—Pruritus—Methotrexate—ankylosing spondylitis	0.000243	0.00226	CcSEcCtD
Cephalexin—Diarrhoea—Methotrexate—ankylosing spondylitis	0.000235	0.00218	CcSEcCtD
Cephalexin—Dizziness—Methotrexate—ankylosing spondylitis	0.000227	0.00211	CcSEcCtD
Cephalexin—Vomiting—Methotrexate—ankylosing spondylitis	0.000219	0.00203	CcSEcCtD
Cephalexin—Rash—Methotrexate—ankylosing spondylitis	0.000217	0.00201	CcSEcCtD
Cephalexin—Dermatitis—Methotrexate—ankylosing spondylitis	0.000217	0.00201	CcSEcCtD
Cephalexin—Headache—Methotrexate—ankylosing spondylitis	0.000215	0.002	CcSEcCtD
Cephalexin—Nausea—Methotrexate—ankylosing spondylitis	0.000204	0.00189	CcSEcCtD
